Ortaldo J R, Mantovani A, Hobbs D, Rubinstein M, Pestka S, Herberman R B
Int J Cancer. 1983 Mar 15;31(3):285-9. doi: 10.1002/ijc.2910310306.
Ten species of purified human leukocyte interferon were tested for their ability to modulate the cytolytic activity of natural killer (NK) cells and the cytolytic and cytostatic activities of monocytes. The interferon species were tested at several antiviral titers and examined for quantitative differences in their ability to modulate immunological function. At the higher doses of interferon (i.e., greater than 500 units) all of the interferon species demonstrated significant augmentation of cytolysis and cytostasis. However, when low levels (i.e., 10-50 units) of interferon were employed, appreciable differences between the various interferon species were seen. A similar pattern of relative potency among the various species of pure leukocyte interferon was seen for augmentation of cytolysis by monocytes and NK cells. In contrast, a different pattern of relative potency was observed for augmentation of cytostasis. These results demonstrated substantial quantitative differences (as much as 100-fold) in the ability of the various species of human leukocyte interferon to induce significant levels of augmentation of these cell-mediated functions. Such results should have significant impact in choosing a specific interferon species for appropriate clinical trials.
对十种纯化的人白细胞干扰素进行了测试,以检测它们调节自然杀伤(NK)细胞的细胞溶解活性以及单核细胞的细胞溶解和细胞抑制活性的能力。在几种抗病毒效价下对这些干扰素进行了测试,并检查了它们在调节免疫功能能力方面的定量差异。在较高剂量的干扰素(即大于500单位)下,所有种类的干扰素均显示出细胞溶解和细胞抑制作用的显著增强。然而,当使用低水平(即10 - 50单位)的干扰素时,不同种类的干扰素之间出现了明显差异。在单核细胞和NK细胞增强细胞溶解方面,各种纯白细胞干扰素的相对效力呈现出类似的模式。相比之下,在增强细胞抑制方面观察到了不同的相对效力模式。这些结果表明,各种人白细胞干扰素在诱导这些细胞介导功能显著增强的能力方面存在很大的定量差异(高达100倍)。这样的结果对于选择特定的干扰素种类进行适当的临床试验应该具有重大影响。